Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

IntraBiotics secures $3.5mm with private placement

Executive Summary

IntraBiotics Pharmaceuticals (antibacterials and antifungals) has secured about $3.5mm through a private placement of Series A preferred stock convertible to approximately 1.8mm common shares at $1.90 apiece, and warrants to purchase about 920k common shares at an exercise price of $2.07 each.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Other
    • Venture Financing

Related Companies

UsernamePublicRestriction

Register